Trilogy International Partners Inc (TSE:TRL) had its target price cut by TD Securities from C$10.50 to C$10.00 in a report published on Tuesday morning. They currently have a buy rating on the specialty pharmaceutical company’s stock.

Separately, Scotiabank decreased their target price on shares of Trilogy International Partners from C$12.50 to C$11.00 and set an outperform rating on the stock in a report on Thursday, August 10th.

Trilogy International Partners (TSE:TRL) opened at 6.95 on Tuesday. The firm has a 50-day moving average of $7.37 and a 200-day moving average of $8.67. The firm’s market capitalization is $307.54 million. Trilogy International Partners has a 52-week low of $5.46 and a 52-week high of $10.48.

TRADEMARK VIOLATION NOTICE: This article was first reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at

About Trilogy International Partners

Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.

Receive News & Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.